Cargando…

Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective

Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate deba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bose, Debdipta, Gogtay, Nithya Jaideep, Rajan, Sujeet K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272424/ https://www.ncbi.nlm.nih.gov/pubmed/34259182 http://dx.doi.org/10.4103/lungindia.lungindia_883_20

Ejemplares similares

The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal
por: Rajan, Sujeet, et al.
Publicado: (2020)

Investigator preparedness for monitoring and audits
por: Ravi, Renju, et al.
Publicado: (2018)

Investigator-initiated studies: Challenges and solutions
por: Konwar, Mahanjit, et al.
Publicado: (2018)

Data justice and data solidarity
por: Braun, Matthias, et al.
Publicado: (2022)

Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population
por: Rajan, Sujeet K., et al.
Publicado: (2014)

An audit of reporting of conflict of interest policies among three stakeholders in Indian biomedical journals
por: Bose, Debdipta, et al.
Publicado: (2020)

An audit of studies registered retrospectively with the Clinical Trials Registry of India: A one year analysis
por: Birajdar, Amit R., et al.
Publicado: (2019)

Social Inequality and Solidarity in Times of COVID-19
por: Stok, F. Marijn, et al.
Publicado: (2021)

Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: A five-year audit
por: Bose, Debdipta, et al.
Publicado: (2020)

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
por: Aleissa, Muneerah M., et al.
Publicado: (2020)

Commoning genomic solidarity to improve global health equality
por: Zhang, Joy Y.
Publicado: (2023)

Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial
por: Nevalainen, Olli P. O., et al.
Publicado: (2022)

Addressing challenges due to the COVID-19 pandemic – A site and investigator perspective
por: Ranganathan, Priya, et al.
Publicado: (2020)

Research methodology workshops: A small step towards practice of evidence-based medicine
por: Gogtay, Nithya Jaideep
Publicado: (2018)

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Publicado: (2022)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
por: Sullivan, John T.
Publicado: (2022)

Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators
por: Figer, Brinal, et al.
Publicado: (2021)

Research, residents, and registrars – getting it right
por: Saha, Shruti, et al.
Publicado: (2022)

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed
por: Figueroa, J Peter, et al.
Publicado: (2021)

Caution About Truncation-By-Death in Clinical Trial Statistical Analysis: A Lesson from Remdesivir
por: Deng, Yuhao, et al.
Publicado: (2021)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Transmission-Blocking Preventive Measures for Infectious Diseases: Altruism, Solidarity, and the Common Good
por: Garber, Laine, et al.
Publicado: (2021)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Should remdesivir be recommended in France in the early stage of COVID-19
por: Martin, Martinot
Publicado: (2022)

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
por: Gupte, Vaishali, et al.
Publicado: (2022)

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
por: Davis, Matthew R., et al.
Publicado: (2020)

Solidarity
por: Staff Association
Publicado: (2011)

Solidarity
por: Staff Association
Publicado: (2011)

Solidarity
por: Association ensemble pour N'DIAGO
Publicado: (2012)

Solidarity
por: Association Ensemble pour N'Diago
Publicado: (2012)

Solidarity
por: Terre des hommes
Publicado: (2010)

Solidarity
por: Staff Association
Publicado: (2012)

Evaluation of clinical trials done for orphan drugs versus nonorphan drugs in infectious diseasesan eleven year analysis [2010-2020]
por: Kudyar, Palvi, et al.
Publicado: (2023)

Remdesivir: Remedy the world is waiting for?
por: Suranagi, Umesh Devappa, et al.
Publicado: (2020)

Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD
por: Dumra, Harjit, et al.
Publicado: (2022)

Justifying the unethical: Are we following the wrong trend regarding authorship? Perspective from Pakistan
por: Abbas, Khawar, et al.
Publicado: (2022)

Saltman on solidarity
por: Brown, Lawrence D., et al.
Publicado: (2015)

Reporting of Randomized Controlled Trials: Will it ever improve?
por: Gogtay, Nithya J.
Publicado: (2019)

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h185pvplm0ouaoj683nejj365s